IPCR Events

The 2025 Symposium on May 10, 2025 featured the latest findings in diagnosis and treatment, along with prevention and exercise tips.

Please click to view the talks below.

Welcome and Introduction

Peter Nelson, MD

Session 1 - PROSTATE CANCER: RISK and SELF-MANAGEMENT TIPS and SKILLS

Prostate Cancer – Inheritance and Family Risk

Burcu F. Darst, PhD

Nutritional Perspectives in Prostate Cancer

Hannah Brady, RDN, CSO, CD

Evidence Based Integrative Approaches for Prostate Cancer

Shannon Fogh, MD ABOIM

Exercise and Prostate Cancer

Dong-Woo Kang, PhD, CEP

Q&A Session 1

Burcu Darst, Hannah Brady, Shannon Fogh, Dong-Woo Kang

Session 2 - TREATING LOCALIZED PROSTATE CANCER – NEW APPROACHES

Pathology: Artificial Intelligence and Real Intelligence

Michael Haffner MD PhD,   

New Approaches for Localized PC

Dan Lin, MD

Advances in Radiation Therapy

Martin Ma, MD, PhD

Prostate Cancer Survivorship: The Road to “Life as Usual”

Marah C. Hehemann, MD

Q&A Session 2

Michael Haffner, Dan Lin, Martin Ma, Marah Hehemann

Session 3 - ADVANCES IN TREATING ADVANCED PROSTATE CANCER

Clinical Trials – Who, What, When and Why

Bruce Montgomery, MD

New Treatment Approvals and Clinical Trials

Michael Schweizer, MD

Pluvicto and Beyond

Amir Iravani, MD, FRACP

Immune Therapy – Innovation and Next Steps

Ruben Raychaudhuri MD

Q&A Session 3

Bruce Montgomery, Mike Schweizer, Amir Iravani, Ruben Raychaudhuri

Closing Remarks

Peter Nelson, MD

The 2024 Symposium on May 11, 2024 featured the latest findings in diagnosis and treatment, along with prevention and exercise tips.

Please click to view the talks below.

Welcome and Introduction

• Peter Nelson, MD

Session 1 - Prostate Cancer: Risk and Interventions

Prostate Cancer Genetics

• Burcu Darst, PhD

Cook for Your Life

• Heather Greenlee, PhD

The Ozempic Weight Loss Revolution - Should Everyone Jump on the Train?

• Marian Neuhouser, PhD
  

The Prostate Cancer Active Lifestyle Study

• Jonathan Wright, MD

Question and Answer: Session 1

• Wright, Neuhouser, Greenlee, Darst
  

Session 2 - Diagnosis, Disparities, and Survivorship

Prostate Cancer Disparities: Community Partnered Approaches to Improving Equity

• Jenney Lee

Digital Pathology – AI and Cancer Diagnosis

• Michael Haffner, MD, PhD

PSMA - Imaging and Treatment

• Delphine Chen, MD

Prostate Cancer Survivorship: The Road to 'Life as Usual'

• Thomas Walsh, MD, & Marah Hehemann, MD
  

Question and Answer: Session 2

• Walsh, Hehemann, Chen, Haffner, Lee

Session 3 - Advances in Treating Prostate Cancer

Clinical Trials - Investigator and Patient Perspectives

• Bruce Montgomery, MD

New Approaches for Treating High Risk Prostate Cancer

• Dan Lin, MD

New Treatment Approvals and Clinical Trials

• Michael Schweizer, MD

Immune Therapy: Challenges and Next Steps

• Jessica Hawley, MD, MS

Question and Answer: Session 3

• Hawley, Schweizer, Lin, Montgomery
  

Closing Remarks

• Peter Nelson, MD
  

The IPCR Symposium in June 2023 featured the latest findings in diagnosis and treatment, as well as hands-on lab activities and yoga sessions.

Please click to view the talks below.

Introduction and Welcome

• Peter Nelson, MD
  

Hereditary Prostate Cancer- Updates from GENTLeMEN

• Heather Cheng, MD, PhD

Prostate Cancer Disparities

• Yaw Nyame, MD, MS, MBA

The Microbiome: Impact  on Cancer Risk and Treatment

• Dave Fredricks, MD

"Prehabilitation" - Faster Recovery and Better Outcomes

• Sarah Psutka, MD

Session 1 - Q&A

Digital Pathology - AI and Cancer Diagnosis

• Michael Haffner, MD, PhD

Radiation Therapy - Expanding the Opportunities

• Emily Weg, MD

Patient Driven Research - Your Impact

• John Gore, MD, MS, FACS

Millions of Veterans: Impact on Prostate Cancer

• Bruce Montgomery, MD

Session 2 - Q&A

A Legacy Toward A Cure: Marty Chakoian and Julie Higgins

New Treatment Approvals and Clinical Trials

• Michael Schweizer, MD

Immune Therapy - Challenges and Next Steps

• Evan Yu, MD

PSMA Therapy - Who? What? When?

• Delphine Chen, MD

Session III - Q&A and Conference Wrap-up

Genetics: Risk-based Screening and Hereditary Prostate Cancer

• Heather H. Cheng MD, PhD

Earlier and Combined: New Treatment Paradigms

• Michael Schweizer, MD

Patient Centered Pathology Reports; Present and Future Microscopy

• Larry True, MD

Polygenic Risk of Prostate Cancer

• Burcu Darst, PhD

Radiation Therapy: Expanding the Opportunities

• Emily Weg, MD

The IPCR Symposium on June 5, 2021 featured the latest research discoveries in the field of prostate cancer.

View the full symposium

Welcome

• Dr. Peter Nelson

Prostate Cancer: Disparity, Risk and Quality of Life

Diet and Prostate Cancer

• Dr. Marian Neuhouser

Nutritional Supplements: Evidence and Science

• Dr. Jeannette Schenk

Prostate Cancer Disparities

• Dr. Yaw Nyame

Treatment Side-Effects: The Patients' Perspective

• Dr. John Gore

Q and A

Prostate Cancer Prevention

• Dr. Dan Lin

Immunotherapy: State of the Field

• Dr. John Lee

Genetics: the GENTLEMEN Study

• Dr. Heather Cheng

Advances in Treating Advanced Prostate Cancer

Imaging: State of the Field

• Dr. Evan Yu

Precision Treatment

• Dr. Bruce Montgomery

Closing

• Dr. Peter Nelson

Welcome

• Dr. Peter Nelson

Session 1 - Prostate Cancer: Disparity, Risk & Quality of Life

Racial disparities in prostate cancer — time to make a difference

• Dr. Ruth Etzioni

Inherited Risk: GENTleMEN

• Dr. Heather Cheng

Diet and Prostate Cancer

• Dr. Marian Neuhouser

Exercise Interventions and Prostate Cancer

• Dr. Jonathan Wright

Enhancing Quality of Life

• Dr. Niels Johnsen

Prostate Cancer: Disparity, Risk and Quality of Life Q&A

Session 2: New Imaging Biomarkers and Treatment Implications

The New Pathology (Light Sheet)

• Dr. Larry True & Dr. Nick Reder

PET Imaging: A Window Into New Treatment Opportunities

• Dr. Manuela Matesan

Oligometastatic Prostate Cancer – Current Data/Ongoing Studies

• Dr. Dan Lin

Targeted Radiation Therapy: Local Recurrence/Distant Metastasis

• Dr. Jing Zeng

New Imaging Biomarkers and Treatment Implications Q & A

Session 3: Advances in Treating Advanced Prostate Cancer

Improving Survival with Combination Therapy

• Dr. Michael Schweizer

Immunotherapy: State of the Field + CAR T

• Dr. John Lee

Prostate Cancer Tumor Board (2 cases)

• Dr. Bruce Montgomery & Dr. Evan Yu

Advances in Treating Advanced Prostate Cancer Q & A

Closing Video

• Dr. Peter Nelson

Our thanks to the generous supporters who helped raise $2.1 million (and still counting) in the fight against prostate cancer!